Literature DB >> 26733603

The role of bile acids in metabolic regulation.

Libor Vítek1, Martin Haluzík2.   

Abstract

Bile acids (BA), long believed to only have lipid-digestive functions, have emerged as novel metabolic modulators. They have important endocrine effects through multiple cytoplasmic as well as nuclear receptors in various organs and tissues. BA affect multiple functions to control energy homeostasis, as well as glucose and lipid metabolism, predominantly by activating the nuclear farnesoid X receptor and the cytoplasmic G protein-coupled BA receptor TGR5 in a variety of tissues. However, BA also are aimed at many other cellular targets in a wide array of organs and cell compartments. Their role in the pathogenesis of diabetes, obesity and other 'diseases of civilization' becomes even more clear. They also interact with the gut microbiome, with important clinical implications, further extending the complexity of their biological functions. Therefore, it is not surprising that BA metabolism is substantially modulated by bariatric surgery, a phenomenon contributing favorably to the therapeutic effects of these surgical procedures. Based on these data, several therapeutic approaches to ameliorate obesity and diabetes have been proposed to affect the cellular targets of BA.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  bariatric surgery; bile acids; diabetes; energy homeostasis; obesity

Mesh:

Substances:

Year:  2016        PMID: 26733603     DOI: 10.1530/JOE-15-0469

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  37 in total

Review 1.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

Review 2.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

3.  The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants.

Authors:  Masaru Tanaka; Masafumi Sanefuji; Seiichi Morokuma; Misako Yoden; Rie Momoda; Kenji Sonomoto; Masanobu Ogawa; Kiyoko Kato; Jiro Nakayama
Journal:  Gut Microbes       Date:  2019-09-24

Review 4.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

5.  Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.

Authors:  Fayth L Miles; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Danijel Djukovic; Timothy W Randolph; Ali Shojaie; Mario Kratz; Meredith A J Hullar; Paul D Lampe; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe
Journal:  Food Funct       Date:  2017-09-20       Impact factor: 5.396

Review 6.  Gut Microbiota: Modulation of Host Physiology in Obesity.

Authors:  Vandana Nehra; Jacob M Allen; Lucy J Mailing; Purna C Kashyap; Jeffrey A Woods
Journal:  Physiology (Bethesda)       Date:  2016-09

Review 7.  Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases.

Authors:  Er-Teng Jia; Zhi-Yu Liu; Min Pan; Jia-Feng Lu; Qin-Yu Ge
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

8.  Cholecystectomy: a way forward and back to metabolic syndrome?

Authors:  Gabriella Garruti; David Q-H Wang; Agostino Di Ciaula; Piero Portincasa
Journal:  Lab Invest       Date:  2018-01       Impact factor: 5.662

9.  Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial.

Authors:  Reza Nemati; Jun Lu; Dech Dokpuang; Michael Booth; Lindsay D Plank; Rinki Murphy
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

Review 10.  [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].

Authors:  S C Bischoff
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.